Hippo Dx

Hippo Dx, a MedTech company, was founded in 2020 out of the need for automation, standardisation, and digitisation of skin prick allergy testing. Today, 30% of the world’s population suffers from allergies, while 45% face an incorrect initial diagnosis. The limitation of manual testing prompted Senne Gorris, an ENT surgeon, to envision an innovative solution. Joined by a team of mechatronics and software engineers, they developed S.P.A.T. (Skin Prick Automated Test), a state-of-the-art medical device for allergy testing.

S.P.A.T. combines evidence-based medicine with pioneering technology to provide faster, more efficient and more consistent allergy testing. The automated skin prick test reduces result variability, streamlines the testing process, and lowers the administrative tasks and hands-on time for healthcare professionals. This enables them to dedicate more time to what truly matters: providing optimal care for patients. Moreover, Patients experience the procedure more comfortable and less painful.

For more information, visit: www.hippo-dx.com